The Culture Media Market is undergoing a dynamic transformation, responding to the surging needs of biopharmaceutical ...

Tiziana Life Sciences has commenced patient dosing at Yale in its Phase 2a trial of intranasal Foralumab for non‑active SPMS, ...

Transitioning into biotech manufacturing from industries like pharma, engineering, or food production can be strategic with ...

Clinical trials are steadily becoming more complex, and the systems that support them must evolve in parallel to ensure ...

Science and technology rely on each other. Scientific progress fuels new technologies, while better technology helps science ...

Marketing approval allows imminent commercialization of the Colovac device in key EU markets PARIS, FRANCE AND TAMPA, FL / ACCESS Newswire / August 14, 2025 / SafeHeal®, a leading innovator in the ...

MADISON, MS / ACCESS Newswire / August 14, 2025 / CLUB4 Fitness, one of the fastest-growing fitness brands in the U.S., today announced a series of key executive promotions designed to support its ...

STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production ...

PM ET HOUSTON, TX / ACCESS Newswire / August 14, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel ...

The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately 35% versus net Q1 2025 revenue of ...

TAMPA, FLORIDA / ACCESS Newswire / August 14, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital ...

Dr. Gruber provides a guide for surgeon evaluation alongside complication prevention strategies and domestic alternative options which patients should consider. TAMPA, FLORIDA / ACCESS Newswire / ...